Pet Cloning Market Report 2026

Pet Cloning Market Overview

• Pet Cloning market size has reached to $4.32 billion in 2025 • Expected to grow to $8.28 billion in 2030 at a compound annual growth rate (CAGR) of 13.5% • Growth Driver: Rising Pet Ownership Rates Drive Growth In The Pet Cloning Market • North America was the largest region in 2025.

What Is Covered Under Pet Cloning Market?

Pet cloning is a biotechnological process that involves creating a genetically identical copy of a pet animal. This is typically achieved through somatic cell nuclear transfer (SCNT), where the nucleus of a donor cell is transferred into an egg cell that has had its nucleus removed. The resulting embryo is then implanted into a surrogate mother to develop into a cloned pet with identical genetic makeup to the original animal. The main types of pet cloning are deceased pet cloning and alive pet cloning. Deceased pet cloning refers to the process of creating a genetic duplicate of a deceased pet using preserved cells or tissues to replicate its characteristics and traits. The technology includes somatic cell nuclear transfer, gene editing, and others, catering to a wide array of applications including dogs, cats, horses, birds, reptiles, and others. Diverse end users encompass pet owners, research institutes, breeding centers, zoos, and conservation programs.

What Is The Pet Cloning Market Growth Forecast?

The pet cloning market size is expected to see rapid growth in the next few years. It will grow to $8.28 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to expansion of genetic preservation programs, increasing awareness and acceptance of pet cloning, technological innovations in cloning methods, growth in luxury pet services, rising investment in research institutes and breeding centers. Major trends in the forecast period include rising demand for personalized pet cloning services, increasing research in genetic preservation of pets, growth in ethical and legal discussions around pet cloning, adoption of advanced cloning techniques in companion animals, expansion of cloning services in luxury pet markets.

Global Pet Cloning Market Segmentation

1) By Product Or Type: Deceased Pet Cloning, Alive Pet Cloning 2) By Technique: Somatic Cell Nuclear Transfer, Gene Editing, Other Techniques 3) By Application: Dogs, Cats, Horses, Other Applications 4) By End-User: Pet Owners, Research Institutes, Breeding Centers, Zoos, Conservation Programs Subsegments: 1) By Deceased Pet Cloning: Full Pet Cloning, Partial Pet Cloning 2) By Alive Pet Cloning: Standard Cloning, Genetic Preservation And Cloning

What Are The Drivers Of The Pet Cloning Market?

The rising pet ownership rates are expected to propel the growth of the pet cloning market going forward. Pet ownership refers to the responsibility and care taken by individuals or households in providing for the needs, well-being, and companionship of domesticated animals kept primarily for pleasure rather than utility. The rising pet ownership rates are due to factors such as lifestyle changes, the humanization of pets, and higher disposable incomes. Pet cloning offers pet owners the opportunity to preserve the genetic identity of beloved animals, potentially providing comfort and continuity in the companionship experience. For instance, in April 2025, according to the Canadian Animal Health Institute, a Canada-based trade association, in 2024, Canada was home to an estimated 7.2 million dogs and 8.2 million cats, making pets an integral part of more than half of Canadian households. Therefore, the rising pet ownership rates are driving the growth of the pet cloning industry. The increasing disposable income and pet spending is expected to propel the growth of the pet cloning market going forward. Pet spending refers to the financial expenditures made by individuals, households, or entities on goods, services, and care related to owning and maintaining a companion animal. The increasing disposable income and pet spending is rising due to higher economic growth and more people treating pets as family members, willing to invest in their care and well-being. Disposable income supports pet cloning by enabling owners to afford the high costs associated with advanced reproductive technologies, reflecting a willingness to invest in preserving cherished pets and extending emotional bonds. For instance, in February 2025, according to the report published by pet business professor, a US- based agency, U.S. pet owners spent approximately $13.42 billion on pet services up 8.5 % from 2022’s $12.36 billion reflecting sustained growth in grooming, boarding, and care utilization. Therefore, the increasing disposable income and pet spending is the growth of the pet cloning industry.

Key Players In The Global Pet Cloning Market

Major companies operating in the pet cloning market are Trans Ova Genetics, Genetix Biotech Asia Pvt. Ltd., PPL Therapeutics, VectorBuilder Inc., Sinogene Pet Cloning, ViaGen LC, BioArts International, Boyalife Group, Cuddle clones, Gemini Genetics, PERPETUATE INC, Sooam Biotech, Oak Villlage Animal Hospital, Bella Vista Animal Hospital, BioVenic, Cyagra LLC, Embryll Life Sciences, My friend Again, Petslify, RNL Bio

What Are Latest Mergers And Acquisitions In The Pet Cloning Market?

In November 2025, Colossal Biosciences Inc., a US based biotechnology company specializing in de extinction, genetic engineering, and conservation biology solutions, acquired Viagen Pets and Equine for an undisclosed amount. With this acquisition, Colossal aimed to accelerate and scale its animal cloning and genetic preservation capabilities, enhancing its technological platform and expanding its market reach into commercial pet cloning services and advanced reproductive technologies for companion animals and endangered species alike. Viagen Pets and Equine is a US based provider of advanced animal cloning, genetic preservation, and cryopreservation services for pets, equine, livestock, and endangered species.

Regional Outlook

North America was the largest region in the pet cloning market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Pet Cloning Market?

The pet cloning market consists of revenues earned by entities by providing services such as genetic counseling services, veterinary support for cloning procedures, DNA banking services, and post-cloning care and rehabilitation programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The pet cloning market also includes sales of cloning kits, genetic preservation solutions, pet cloning equipment sales, and customized cloning protocols. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.